Division of Nephrology, Department of Internal Medicine, Yeungnam University Hospital, Daegu, Korea.
Nephrology (Carlton). 2012 Feb;17(2):141-7. doi: 10.1111/j.1440-1797.2011.01518.x.
Blind peritoneal dialysis (PD) catheter instrumentation with a Tenckhoff trocar is performed without direct visualization of the peritoneum. This method requires the least equipment, it is safe and it can be performed mainly by nephrologists. We report here on our long-term experience with this method as performed by nephrologists.
We reviewed the medical records at Yeungnam University Hospital in Korea and identified all the patients who had undergone blind PD catheter instrumentation with a Tenckhoff trocar by nephrologists. Four hundred and three patients were enrolled.
Early complications occurred in 7.7% (four patients with pericatheter bleeding, one patient with pleural leakage, two patients with migration, two patients with omental wrapping, three patients with exit site/tunnel infection and 19 patients with peritonitis). The late mechanical complications included eight cases of hernia, three cases of catheter extrusion, five cases of leakage, four cases of migration and five cases of omental wrapping. Exit site/tunnel infection and peritonitis occurred at a rate of 0.067 and 0.40 episodes/year, respectively. The intervention free survival rate was 84.5% at one year and 63.3% at 5 years. The catheter survival rate was 96.5% at one year and 83.6% at 5 years.
This study provides evidence that blind PD catheter placement with a Tenckhoff trocar requires the least equipments, and it is easy to perform. Therefore, if the general anesthesia is impossible or equipment, such as fluoroscopy and laparoscopy, were not available, this method may be an alternative choice for PD catheter placement.
经皮穿刺腹膜透析(PD)导管置入术是在不直接观察腹膜的情况下进行的。这种方法所需设备最少,安全,主要由肾病医生完成。我们在此报告我们使用这种方法的长期经验,这些经验是由肾病医生完成的。
我们回顾了韩国延世大学医院的病历,确定了所有由肾病医生进行经皮穿刺腹膜透析导管置入术的患者。共有 403 名患者入组。
早期并发症发生率为 7.7%(4 例导管周围出血,1 例胸腔渗漏,2 例迁移,2 例网膜包裹,3 例出口/隧道感染和 19 例腹膜炎)。晚期机械并发症包括 8 例疝,3 例导管脱出,5 例渗漏,4 例迁移和 5 例网膜包裹。出口/隧道感染和腹膜炎的发生率分别为 0.067 和 0.40 例/年。1 年和 5 年时无干预生存率分别为 84.5%和 63.3%。1 年和 5 年时导管生存率分别为 96.5%和 83.6%。
本研究表明,经皮穿刺腹膜透析导管置入术使用 Tenckhoff 套管针需要的设备最少,易于操作。因此,如果无法进行全身麻醉或缺乏透视和腹腔镜等设备,这种方法可能是 PD 导管置入的替代选择。